Cargando…
Randomized trial of different initial intravenous immunoglobulin regimens in Kawasaki disease
BACKGROUND: We aimed to assess the efficacy of different initial intravenous immunoglobulin (IVIG) regimens in Kawasaki disease (KD) patients to find more cost‐effective therapy options. METHODS: A multicenter, open‐label, blind‐endpoint randomized controlled trial was conducted from January 2014 to...
Autores principales: | He, Lan, Liu, Fang, Yan, Weili, Huang, Min, Huang, Meirong, Xie, Lijian, Guo, Ying, Xu, Xinyi, Chu, Chen, Wu, Lin, Liang, Xuecun, Sun, Shuna, Wang, Feng, Zhao, Lu, Zhao, Quming, Ma, Xiaojing, Xie, Liping, Huang, Guoying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362187/ https://www.ncbi.nlm.nih.gov/pubmed/33600060 http://dx.doi.org/10.1111/ped.14656 |
Ejemplares similares
-
Prediction for Intravenous Immunoglobulin Resistance Combining Genetic Risk Loci Identified From Next Generation Sequencing and Laboratory Data in Kawasaki Disease
por: Chen, Liqin, et al.
Publicado: (2020) -
Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease
por: Li, Wei, et al.
Publicado: (2022) -
Risk Factors for Failure of Initial Intravenous Immunoglobulin Treatment in Kawasaki Disease
por: Cha, Sungho, et al.
Publicado: (2008) -
Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023) -
Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease
por: Xie, Tian, et al.
Publicado: (2017)